238 related articles for article (PubMed ID: 15905533)
21. Inhibition of CD8+ T cell-derived CD40 signals is necessary but not sufficient for Foxp3+ induced regulatory T cell generation in vivo.
Liu D; Ferrer IR; Konomos M; Ford ML
J Immunol; 2013 Aug; 191(4):1957-64. PubMed ID: 23858029
[TBL] [Abstract][Full Text] [Related]
22. Defective CD8 Signaling Pathways Delay Rejection in Older Recipients.
Bedi DS; Krenzien F; Quante M; Uehara H; Edtinger K; Liu G; Denecke C; Jurisch A; Kim I; Li H; Yuan X; Ge X; ElKhal A; Tullius SG
Transplantation; 2016 Jan; 100(1):69-79. PubMed ID: 26356176
[TBL] [Abstract][Full Text] [Related]
23. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy.
Chen Y; Heeger PS; Valujskikh A
J Immunol; 2004 May; 172(9):5456-66. PubMed ID: 15100287
[TBL] [Abstract][Full Text] [Related]
24. The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity.
Watanabe S; Kagamu H; Yoshizawa H; Fujita N; Tanaka H; Tanaka J; Gejyo F
J Immunol; 2003 Dec; 171(11):5828-36. PubMed ID: 14634092
[TBL] [Abstract][Full Text] [Related]
25. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.
Gregori S; Casorati M; Amuchastegui S; Smiroldo S; Davalli AM; Adorini L
J Immunol; 2001 Aug; 167(4):1945-53. PubMed ID: 11489974
[TBL] [Abstract][Full Text] [Related]
26. IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2.
Jackaman C; Bundell CS; Kinnear BF; Smith AM; Filion P; van Hagen D; Robinson BW; Nelson DJ
J Immunol; 2003 Nov; 171(10):5051-63. PubMed ID: 14607902
[TBL] [Abstract][Full Text] [Related]
27. IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation.
Blachère NE; Morris HK; Braun D; Saklani H; Di Santo JP; Darnell RB; Albert ML
J Immunol; 2006 Jun; 176(12):7288-300. PubMed ID: 16751372
[TBL] [Abstract][Full Text] [Related]
28. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation.
Ensminger SM; Spriewald BM; Sorensen HV; Witzke O; Flashman EG; Bushell A; Morris PJ; Rose ML; Rahemtulla A; Wood KJ
J Immunol; 2001 Jul; 167(1):532-41. PubMed ID: 11418692
[TBL] [Abstract][Full Text] [Related]
29. Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells.
Bullock TN; Yagita H
J Immunol; 2005 Jan; 174(2):710-7. PubMed ID: 15634890
[TBL] [Abstract][Full Text] [Related]
30. CD40/CD154 blockade inhibits dendritic cell expression of inflammatory cytokines but not costimulatory molecules.
Ferrer IR; Liu D; Pinelli DF; Koehn BH; Stempora LL; Ford ML
J Immunol; 2012 Nov; 189(9):4387-95. PubMed ID: 23002440
[TBL] [Abstract][Full Text] [Related]
31. Skin allograft maintenance in a new synchimeric model system of tolerance.
Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
[TBL] [Abstract][Full Text] [Related]
32. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
Hao S; Yuan J; Xiang J
J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
[TBL] [Abstract][Full Text] [Related]
33. Allograft dendritic cell p40 homodimers activate donor-reactive memory CD8+ T cells.
Tsuda H; Su CA; Tanaka T; Ayasoufi K; Min B; Valujskikh A; Fairchild RL
JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467328
[TBL] [Abstract][Full Text] [Related]
34. Complement regulates CD4 T-cell help to CD8 T cells required for murine allograft rejection.
Vieyra M; Leisman S; Raedler H; Kwan WH; Yang M; Strainic MG; Medof ME; Heeger PS
Am J Pathol; 2011 Aug; 179(2):766-74. PubMed ID: 21704012
[TBL] [Abstract][Full Text] [Related]
35. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
36. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
[TBL] [Abstract][Full Text] [Related]
37. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential.
Kelleher M; Beverley PC
J Immunol; 2001 Dec; 167(11):6247-55. PubMed ID: 11714787
[TBL] [Abstract][Full Text] [Related]
38. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
Dobrzanski MJ; Reome JB; Dutton RW
J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
[TBL] [Abstract][Full Text] [Related]
39. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo.
Hara M; Kingsley CI; Niimi M; Read S; Turvey SE; Bushell AR; Morris PJ; Powrie F; Wood KJ
J Immunol; 2001 Mar; 166(6):3789-96. PubMed ID: 11238621
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic effector function of CD4-independent, CD8(+) T cells is mediated by TNF-α/TNFR.
Zimmerer JM; Horne PH; Fiessinger LA; Fisher MG; Pham TA; Saklayen SL; Bumgardner GL
Transplantation; 2012 Dec; 94(11):1103-10. PubMed ID: 23222736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
